3 unknown, 2 not yet recruiting. 3 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Not yet recruiting 1 |
| Phase 3 | 2 | Not yet recruiting 1, Unknown 1 |
Follow DWP16001 0.3mg: new trials by email Literature Review of DWP16001 0.3mg trials Research Report on DWP16001 0.3mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults DWP16001 0.3mg, DWC202407 1,000mg, DWC202408 2mg - Healthy | Phase 1 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 34 | 2024-10-26 | 2024-10-16 |
| Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients DWP16001 Placebo, DWP16001 0.3mg - Type 2 Diabetic Nephropathy | Phase 3 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 348 | 2024-09-23 | 2024-09-20 |
| To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function DWP16001 - Diabetes Mellitus, Type 2 | Phase 1 | Unknown | Daewoong Pharmaceutical Co. LTD. | 24 | 2023-04-13 | 2024-04-08 |
| A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus DWP16001 0.3mg, DWP16001 Placebo - Type 2 Diabetes Mellitus | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 240 | 2023-03-17 | 2024-04-08 |
| To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers DWP16001 - Healthy | Phase 1 | Unknown | Daewoong Pharmaceutical Co. LTD. | 32 | 2023-03-09 | 2023-04-04 |
Daewoong Pharmaceutical Co. LTD. (5)
South Korea (5)